On the stock market since 1987, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Average growth of 6% a year over the last 4 years. Red columns mark years that ended in a loss.
The stock trades 20% below its peak. The market has trimmed its expectations for the company.
Over the last 3 years, sales grew about 8% a year on average.
Sales run at $7.5M a year. A small number, but proof the product has real buyers.
It pays out $0.35 per share each year — regular cash for whoever holds the stock.
A loss of $3.3M against $7.5M in annual sales. And on top of that, sales fell from the year before.
Costs swallow the gains that sales growth brings in.
On our five-subject report card, NNY sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: NNY is a high-risk stock — not yet profitable, and its future rides on its product catching on.